1 – 10 of 326
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
- The label matters : µPET imaging of the biodistribution of low molar mass 89Zr and 18F-labeled poly(2-ethyl-2-oxazoline)
- Insights into the myosin II inhibitory potency of A-ring-modified (S)-blebbistatin analogs
- Justice for pollution-victims in China and Australia
- Sleeping with the enemy? The ethics and politics of being a 'negative fieldworker' in Israel/Palestine
- Discovery of (S)-3′-hydroxyblebbistatin and (S)-3′-aminoblebbistatin : polar myosin II inhibitors with superior research tool properties
- Improved synthesis and comparative analysis of the tool properties of new and existing D-ring modified (S)-blebbistatin analogs
- Mondiale rechtvaardigheid en de toegang tot essentiële geneesmiddelen
- Adherence to continuous positive airway pressure in adults with an intellectual disability
- Eli Lilly v Canada : the uncomfortable liaison between intellectual property and international investment law
- Oude Belgen en jonge Romeinen aan de Blikstraat : wonen en boeren met uitzicht op het Klein Schijn